X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (504) 504
life sciences & biomedicine (484) 484
humans (445) 445
gastroenterology & hepatology (378) 378
gastroenterology and hepatology (292) 292
female (281) 281
male (278) 278
adult (244) 244
inflammatory bowel disease (216) 216
crohn's disease (200) 200
middle aged (196) 196
ulcerative colitis (192) 192
infliximab (126) 126
abridged index medicus (123) 123
treatment outcome (115) 115
crohn disease - drug therapy (113) 113
inflammatory bowel diseases (93) 93
young adult (92) 92
adolescent (90) 90
aged (86) 86
colitis, ulcerative - drug therapy (78) 78
care and treatment (75) 75
crohn disease - genetics (74) 74
risk factors (72) 72
antibodies, monoclonal - therapeutic use (69) 69
case-control studies (64) 64
gastrointestinal agents - therapeutic use (59) 59
genetic predisposition to disease (58) 58
analysis (55) 55
tumor necrosis factor-alpha - antagonists & inhibitors (55) 55
crohns disease (54) 54
inflammatory bowel diseases - drug therapy (53) 53
intestine (52) 52
research (51) 51
pharmacology & pharmacy (49) 49
genetic aspects (48) 48
medical research (48) 48
retrospective studies (48) 48
cohort studies (45) 45
crohn disease - immunology (44) 44
genetics (43) 43
prospective studies (43) 43
gastrointestinal diseases (41) 41
genotype (41) 41
patients (41) 41
follow-up studies (40) 40
inflammation (40) 40
crohn disease - diagnosis (39) 39
monoclonal antibodies (39) 39
severity of illness index (39) 39
anti-inflammatory agents - therapeutic use (38) 38
gastroenterology (38) 38
prognosis (38) 38
clinical trials (37) 37
colitis, ulcerative - genetics (37) 37
crohn’s disease (37) 37
inflammatory bowel diseases - genetics (37) 37
remission induction (37) 37
antibodies, monoclonal, humanized - therapeutic use (36) 36
tumor necrosis factor (36) 36
antibodies (35) 35
biopsy (34) 34
medicine, experimental (34) 34
gene expression (33) 33
inflammatory bowel diseases - immunology (33) 33
polymorphism, single nucleotide (33) 33
child (32) 32
animals (31) 31
belgium (31) 31
endoscopy (31) 31
intestinal mucosa - pathology (31) 31
crohn disease - pathology (29) 29
immunosuppressive agents - therapeutic use (29) 29
studies (29) 29
time factors (29) 29
aged, 80 and over (28) 28
colitis, ulcerative - immunology (28) 28
genes (28) 28
clinical medicine (27) 27
colitis, ulcerative - pathology (27) 27
genetics & heredity (27) 27
ibd (27) 27
adalimumab (26) 26
colon (26) 26
enzyme-linked immunosorbent assay (26) 26
genome-wide association study (26) 26
health aspects (26) 26
crohn disease - blood (25) 25
double-blind method (25) 25
phenotype (25) 25
rodents (25) 25
surgery (25) 25
therapeutic drug monitoring (25) 25
biomarkers - blood (24) 24
colitis (24) 24
immunology (24) 24
medicine (24) 24
viral antibodies (24) 24
colitis, ulcerative - diagnosis (23) 23
general & internal medicine (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2014, Volume 384, Issue 9940, pp. 309 - 318
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 01/2017, Volume 152, Issue 2, pp. 374 - 388.e4
...Clara Abraham Parambir S. Dulai Séverine Vermeire William J. Sandborn The intestinal lamina propria contains a complex population of immune cells that balance... 
Gastroenterology and Hepatology | Crohn’s Disease | Therapy | Intestine | Ulcerative Colitis | Crohn's Disease | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Inflammatory Bowel Diseases - drug therapy | Transforming Growth Factor beta - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Oligonucleotides - therapeutic use | Signal Transduction | Humans | Inflammatory Bowel Diseases - immunology | Antibodies, Monoclonal - therapeutic use | Sphingosine - immunology | Molecular Targeted Therapy | Ustekinumab - therapeutic use | Interleukin-23 - immunology | Lysophospholipids - immunology | Sphingosine - analogs & derivatives | Smad7 Protein - immunology | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Th17 Cells - immunology | Janus Kinases - immunology | Pyrroles - therapeutic use | Cytokines - immunology | Inflammatory bowel diseases | Care and treatment | Colitis | Interleukins | Therapeutics | Homeopathy | Materia medica and therapeutics | Medical research | Biological response modifiers | Transforming growth factors | Sulfates | Dextran | Medicine, Experimental | Interferon | Ulcerative colitis | Index Medicus | Abridged Index Medicus | ulcerative colitis | intestine | therapy | Crohn’s disease
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10006, pp. 1825 - 1834
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2017, Volume 390, Issue 10090, pp. 135 - 144
Summary Background PF-00547659 is a fully human monoclonal antibody that binds to human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) to selectively... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Gastrointestinal Agents - administration & dosage | Male | Treatment Outcome | Colitis, Ulcerative - pathology | Remission Induction | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Injections, Subcutaneous | Adolescent | Gastrointestinal Agents - therapeutic use | Adult | Female | Aged | Gastrointestinal Agents - adverse effects | Colitis, Ulcerative - drug therapy | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Clinical trials | Monoclonal antibodies | Medicine, Experimental | Medical colleges | Medical research | Ulcerative colitis | Immunoglobulins | MAdCAM-1 antigen | Mucosa | Injection | Patients | Evidence-based medicine | Bleeding | Cell adhesion molecules | Cell adhesion & migration | Inflammatory bowel disease | Endoscopes | Intestine | Immunotherapy | Rectum | Cell adhesion | Remission | Safety | Colon | Cell migration | Nervous system | Homing | Randomization | Endoscopy | Drug dosages | Tumor necrosis factor-α | Index Medicus | Abridged Index Medicus
Journal Article